Drug Maker Sandoz To Pay $195 Million To Settle US Case
Sandoz, a subsidiary of Swiss pharmaceutical giant Novartis, has agreed to pay $195 million to avoid trial on charges it conspired to fix prices of generic drugs, US prosecutors announced Monday.
No comments:
Post a Comment